COVID-19 Vaccine Damage (National Campaign)

Our Government is committed to keeping the public safe during the worst public health crisis of our generation. Preparing for the spread of the coronavirus outbreak is a national priority. And this Government will keep the public informed on how best to protect themselves on the Government website.

The Prime Minister and this Government are committed to keeping the public informed every step of the way about what we’re doing to fight the spread of coronavirus, when we’re doing it and why we’re doing it. At all times we will be led by the science to bring forward the right responses at the right time to this global pandemic.

The Prime Minister is also taking part in a number of technical meetings around modelling the outbreak and spread of coronavirus, to better plan next steps on protecting elderly and vulnerable people, as well as to discuss household isolation and mass gatherings.

For those with symptoms of coronavirus, the NHS has up-to-date guidance on what to do. The Government has also released clear stay-at-home guidance to those who need it.

For employers, those working in care homes, for those working in schools, and more, the Government has also published guidance on how to keep yourself and others safe.

This Campaign is about keeping you informed about Government Action and information to help us all minimise the short, medium and long term impact of Covid-19.

News

Chris Inquires Re Universal Credit & VDPS For Bereaved Relatives

Chris Inquires Re Universal Credit & VDPS For Bereaved Relatives Christopher Chope Conservative, Christchurch To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 22 November 2022 to Question 87733 on Universal Credit: Vaccine Damage Payment Sche

Chris Seeks To Clarify Impact Of Grant For Cominarty Products

Chris Seeks To Clarify Impact Of Grant For Cominarty Products Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, whether the grant of the Marketing Authorisations for Cominarty products on 9 November 2022 will affect (a) immunity

Chris Inquires About Blood Donors And Covid Vaccinations

Chris Inquires About Blood Donors And Covid Vaccinations Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, whether blood donations from people who have not been vaccinated against covid-19 are separately identified; and whether

Chris Seeks Clarity On Vaccination Conditional Marketing Authorisation

Chris Seeks Clarity On Vaccination Conditional Marketing Authorisation Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 November 2022 to Question 83513 on Coronavirus: Vaccination, for what reasons

Chris Seeks Conclusions From MHRA On Post-Vaccination Syndrome

Chris Seeks Conclusions From MHRA On Post-Vaccination Syndrome Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 November to Question 93721 on Coronavirus: Vaccination, what conclusions have been rea

Chris Seeks Assessment Of Post Vaccination Surveillance

Chris Seeks Assessment Of Post Vaccination Surveillance Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 November 2022 to Question 96554 on Cardiovascular Diseases, what assessment he has made of th

Chris Pursues Rationale & Disclosure Of Medical Conditions

Chris Pursues Rationale & Disclosure Of Medical Conditions Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 November 2022 to Question 82160 on Coronavirus: Vaccination, for what reason providing

Chris Seeks Now Unavailable Information On Stevens-Johnson Syndrome

Chris Seeks Now Unavailable Information On Stevens-Johnson Syndrome Christopher Chope Conservative, Christchurch To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 November 2022 to Question 96551 on Stevens-Johnson Syndrome and the ora